Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 24, 2025Journal of the Peripheral Nervous System

Intravenous Efgartigimod or Intravenous Immunoglobulin in Guillain‐Barre Syndrome: An Observational Multicenter Study

View Full Paper
Ask AI
Bookmark
Share

Authors

FZFan ZhouQingdao University of Science and TechnologyTLTao LiBGI Group (China)JLJianfeng LuoUniversity of Science and Technology of China

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/69403bab2d562116f290ce86https://doi.org/10.1111/jns.70072
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans2018 · 411 citations
  2. 2Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies2002 · 170 citations
  3. 3Correlation of the patient's reported outcome Inflammatory‐ RODS with an objective metric in immune‐mediated neuropathies2016 · 44 citations
  4. 4Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis2011 · 967 citations
  5. 5Incat disability score: A critical analysis of its measurement properties2014 · 78 citations